Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues-Reference-Cited by-同舟云学术

Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues

Published:2016-02 Issue:2 Volume:11 Page:203-212
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sunami Kuniko,Furuta Koh,Tsuta Koji,Sasada Shinji,Izumo Takehiro,Nakaoku Takashi,Shimada Yoko,Saito Motonobu,Nokihara Hiroshi,Watanabe Shun-ichi,Ohe Yuichiro,Kohno Takashi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Tyrosine kinase gene rearrangements in epithelial malignancies;Shaw;Nat Rev Cancer,2013

2. New targetable oncogenes in non–small-cell lung cancer;Oxnard;J Clin Oncol,2013

3. Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer;Kwak;New Engl J Med,2010

4. Ceritinib in ALK-rearranged non–small-cell lung cancer;Shaw;New Engl J Med,2014

5. CH5424802 (RO5424802) for patients with ALK-rearranged advanced non–small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study;Seto;Lancet Oncol,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study;Cancer Science;2024-02-25

2. Molecular Testing on Cytology for Gene Fusion Detection;Frontiers in Medicine;2021-07-06

3. Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study;Japanese Journal of Clinical Oncology;2021-05-25

4. MET-dependent solid tumours — molecular diagnosis and targeted therapy;Nature Reviews Clinical Oncology;2020-06-08

5. Neuregulin 1 Fusion–Positive NSCLC;Journal of Thoracic Oncology;2019-08